Latest News

Date Title Topic
09 Aug 2016 FDA Approves Pembrolizumab for Patients with Recurrent or Metastatic HNSCC with Disease Progression on or After Platinum-Containing Chemotherapy Head and neck cancers - Cancer Immunology and Immunotherapy
Glioma
03 Aug 2016 NICE Issues Technology Appraisal Guidance for Nivolumab in Combination With Ipilimumab for Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
03 Aug 2016 New: Bone Sarcoma Guide for Patients
02 Aug 2016 EMA Recommends Extension of Therapeutic Indications for Ibrutinib Haematologic malignancies - Anticancer agents & Biologic therapy
01 Aug 2016 BRCA1 and BRCA2 in Ovarian Cancer
28 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Pegylated Liposomal Formulation of Irinotecan for Metastatic Pancreatic Adenocarcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Jul 2016 Infection-Associated Cancers Epidemiology/Etiology/Cancer Prevention
26 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Lenvatinib in the Treatment of Unresectable Advanced or Metastatic RCC Genitourinary cancers - Anticancer agents & Biologic therapy
26 Jul 2016 Press Release: ESMO Publishes Results of European Consortium Study on the Availability of Anti-neoplastic Medicines
25 Jul 2016 EMA Recommends Extension of Therapeutic Indications for Crizotinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Jul 2016 July 2016 – Image of the Month
22 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Cabozantinib in Advanced RCC Genitourinary cancers - Anticancer agents & Biologic therapy
21 Jul 2016 Press Release: ESMO 2018 Annual Congress to be Held in Munich
20 Jul 2016 PRAC Concludes Review of Idelalisib and Issues Updated Recommendations for Use Haematologic malignancies - Anticancer agents & Biologic therapy